Generative AI (Artificial Intelligence) comes with a promise of offering unparalleled opportunities to life sciences organizations. Yet, the success of the journey grips on how data ready is your company for gen AI. From improving drug discovery to enhancing trials and devising marketing strategies, there is a vast potential to take benefit from the use […]
On average, it takes over 10 years and costs upwards of $2.6 billion to get a new drug from initial discovery to approval by regulatory bodies like the FDA. Moreover, processes like clinical trials are long, complex, and expensive that pharmaceutical companies must undertake to test the safety and efficacy of new medical treatments. A […]
Life sciences industry is experiencing its own gen AI revolution resulting in efficient clinical trials, accelerated dug discovery, quicker document summarizations, chatbots taking over repetitive manual tasks, and we are just getting started. When used effectively, gen AI can assist in almost all the departments and stakeholders right from R&D to commercialization of a drug. […]
